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SYMPOSIUM
The effect of HIV, behavioural change, and STD
syndromic management on STD epidemiology in
sub-Saharan Africa: simulations of Uganda
E L Korenromp, R Bakker, R Gray, M J Wawer, D Serwadda, J D F Habbema
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Sex Transm Infect 2002;78(Suppl I):i55–i63
An assessment was made of how the HIV epidemic may
have influenced sexually transmitted disease (STD)
epidemiology in Uganda, and how HIV would affect the
effectiveness of syndromic STD treatment programmes
during different stages of the epidemic. The dynamic
transmission model STDSIM was used to simulate the
spread of HIV and four bacterial and one viral STD.
Model parameters were quantified using demographic,
behavioural, and epidemiological data from rural Rakai
and other Ugandan populations. The findings suggest
that severe HIV epidemics can markedly alter STD
epidemiology, especially if accompanied by a
behavioural response. Likely declines in bacterial causes
of genital ulcers should be considered in defining
policies on syndromic STD management in severe HIV
epidemics.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Throughout the recent history of sub-SaharanAfrica, sexually transmitted diseases (STD)have been a major cause of mortality and
morbidity.1–3 Colonial and postcolonial socioeco-
nomic and behavioural changes, as well as develop-
ments in biomedical sciences and health care, have
markedly affected STD epidemiology in the 20th
century.1 2 4 5 The rapid growth of cities, with
extensive migration from rural to urban areas,
especially by men without their families, may have
contributed to rapid STD spread by increasing the
practice of prostitution.1 In the 1950s and 1960s,
penicillin probably helped to control the spread of
syphilis. The use of penicillin against STDs and
other illnesses is also likely to have reduced gonor-
rhoea during that period, which may have contrib-
uted to declines in infertility.4 5 However, gonor-
rhoea resistance to penicillin developed rapidly,
and gonorrhoea rates appear to have remained
high up till the 1980s.1 6 For some areas, including
central Africa, increased school attendance prob-
ably contributed to STD reductions through de-
clines in sexual activity by adolescent girls.5 Dur-
ing the 1960s and 1970s, (civil) wars, social
instability, and population movements in re-
sponse to natural disasters may have enhanced
sexual mixing, providing a further mechanism for
STDs to spread again (and probably for HIV to
start spreading), for example in Uganda and
Kenya.2 7 8 In summary, despite some possible
temporary successes in the control of some STD,
before the 1980s the contribution of public health
interventions to curbing STD spread seems in
sub-Saharan Africa to have been limited. Conse-
quently, during this period, STD epidemiology in
sub-Saharan Africa does not conform to the
sequence of stages of increasing control observed
in Western industrialised countries.9
Since the HIV pandemic, STDs and their
control in sub-Saharan Africa have received
increasing attention. Following the insight that
STD, as well as being a marker of sexual (risk)
activity, may enhance HIV transmission,10–15 HIV
prevention policies have adopted STD manage-
ment as an essential component of prevention
programmes.16 STD surveillance was recognised
as a useful comparison of HIV risk assessment,
both for identifying the population subgroups
most at risk and for monitoring time trends in
risk behaviour. Subsequently, several sub-
Saharan Africa countries reported falls in the
rates of STD. Interestingly, some STDs appear to
be more affected than others, with decreases in
chancroid being noted most often17–21; for ulcera-
tions caused by herpes simplex virus type 2
(HSV-2), on the other hand, increases have been
noted, at least among clinic patients and selected
survey populations.18 20 22–24
In this paper, we assess how severe HIV
epidemics as encountered in several sub-Saharan
Africa countries may influence the epidemiology
and control of STDs. We used the epidemiological
transmissionmodel STDSIM (simulationmodel for
STD control) to simulate the spread of HIV and
STDs and interactions between these
infections.25 26 The model was quantified to repre-
sent Uganda, which was one of the first countries
recognising a severe HIV epidemic27–29 and, follow-
ing the end of its civil war in 1986, to adopt a
national AIDS control policy including large scale
implementation of IEC programmes and volun-
tary HIV testing and counselling. During the early
1990s, Uganda was again one of the first countries
to see behavioural risk reduction at a population
level.30–36 In parallel, HIV prevalence stabilised and
appears to have started a slow decline in these
regions since the mid-1990s.31–33 37–40 To understand
the effects of HIV epidemiology and behavioural
change on STD epidemiology and control, we
simulated HIV and STD epidemiology and the
effectiveness of intervention programmes involv-
ing improved STD management over time, both
for Uganda and for a hypothetical population
without any behaviour change.
METHODS
STDSIM model
STDSIM simulates the natural history and trans-
mission of several STDs and HIV, in a dynamic
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population defined by a detailed set of parameters. The model
population consists of individuals with assigned characteris-
tics that change over time. The formation and dissolution of
heterosexual partnerships between individuals, and the
transmission of STDs during contacts between sexual
partners, are modelled as stochastic events.26 41 Recently, the
model was adapted to include the simulation of genital infec-
tion with HSV-2 and the effects of HIV infection on the natu-
ral history and transmission of STDs including HSV-2. The
adapted model allowed us to study the epidemiology of
curable and incurable STDs in relation to HIV.
Simulated populations
The simulation of the HIV/STD epidemic in Uganda was based
on data collected in rural Rakai district, Uganda, in the context
of an STD treatment trial and preceding cohort
studies,28 39 42–45 and previous simulations41 of an STD treatment
trial in rural Mwanza, Tanzania, which also involved a rural
population.46 47 Few data are available on sexual behaviour in
either Uganda or Tanzania before 1989, the time of the first
HIV related surveys. Two assumptions were made to explain
the much higher prevalence of HIV in Uganda than in Tanza-
nia in 1989 (15–25% as compared to 2.5%).39 45 48 First, we esti-
mated that HIV spread had started relatively early in Uganda.
Because the time of HIV introduction in Uganda is not
precisely known and the first AIDS cases were observed in
1982,27 this timepoint was set at 1978, around the time of the
Tanzanian invasion and the start of the civil war. Second, we
assumed that partner change rates had been higher and
one-off contacts more frequent in Uganda during the period of
civil war between 1978 and 1986, reflecting social disruption.
Compared with the first Ugandan behavioural surveys in the
late 1980s, behavioural risk reductions have been observed
during the 1990s. Reported changes include reductions in
numbers of partners, increased condom use, especially in the
younger age groups, and possibly delays in the age of first
sex.30–34 There is anecdotal evidence that in Rakai trading cen-
tres, commercial sex had become less common in the 1990s
compared with the 1980s.45
These behavioural changes were represented in the model
as a 50% reduction in the proportion of males having one-off
sexual contacts (for example with female sex workers) after
1986. In addition, a 25% reduction in partner change rates in
the whole population was assumed after this time. This quan-
tification resulted in adequate fit of the model with respect to
proportions married, numbers of recent partners of men, and
age/sex patterns in data from rural Rakai in 1995 (not shown).
It is of note, however, that the exact magnitudes of change
assumed in the model may be arbitrary, because the two
simulated types of risk behaviour are a simplistic represen-
tation of a spectrum ranging from “hard core prostitution”
through non-commercial one-off contacts and even rape, to
long term relationships with high contact frequency. For the
hypothetical Uganda-like population without behavioural risk
reduction, the assumed behavioural changes in 1986 were
omitted from the simulation.
Assumptions on natural history and transmission of
STD
The STDSIM representations of STD natural history and trans-
mission were based on a review of the scientific literature and
are shown in table 1. The parameterisation for gonorrhoea and
chlamydia has been described before.41
The representation of HSV-2, which resulted in realistic
age/sex patterns in simulated HSV-2 seroprevalence, has been
described elsewhere.49 In brief, the infection was specified to
start with a primary ulcer lasting for a mean of three
weeks.50–54 After healing of this lesion, ulcers would recur at an
average six months interval55 56 for a period of, on average, 15
years, denoted the “early latent stage”. In line with their rela-
tive clinical severity,50 54 herpetic recurrences were assumed to
be less severe in terms of symptoms and infectivity than
primary ulcers. In between recurrences, a low continuous level
of infectivity was assumed, which represented the regular
occurrence of episodes of subclinical shedding in the majority
of HSV-2 infectees.57–61 By the end of the “early latent stage”
patients were assumed no longer to suffer recurrences nor to
be infectious, but to remain seropositive for life.
Chancroid was represented as a continuous ulcerative
episode lasting on average 10 weeks.62 63 Transmission prob-
abilities were specified at a lower level (15–20%; table 1) than
the single available empirical estimate (43%, for male to
female transmission64). This was done in order to have the
Table 1 Representation of natural history and transmission of HIV and sexually transmitted diseases in the STDSIM
simulation of the Uganda HIV epidemic
Infection and stage Mean duration*
Transmission probability†
Cofactor effect on HIV
transmission†‡
Proportion
symptomatic
M⇒F F⇒M M F
HIV
Primary 10 weeks 0.045 0.015 na na na
Asymptomatic 5 years 0.00225 0.00075 na na na
Symptomatic pre-AIDS 2 years 0.00225 0.00075 na na na
AIDS 40 weeks 0.01125 0.00375 na na na
Syphilis
Infectious 6 months 0.3 0.2 10× 80% 50%
Latent 15 years 0 0 na na na
Chancroid 10 weeks 0.20 0.15 25× 90% 70%
HSV-2
Primary ulcer 3 weeks 0.30 0.15 25× 30%
Early latent (with recurrent ulcers) 15 years 0.005§ 0.0025§ na§ na§ na§
Recurrent ulcer 1 week; 0.20 0.10 10× 15% 7.5%
Interval between ulcers 6 months
Late latent Lifelong 0 0 na na na
Gonorrhoea M 9 weeks; 0.22 0.15 5× 50% 20%
F 13 weeks
Chlamydia M 12 weeks; 0.20 0.12 5× 30% 15%
F 16 weeks
*Individual stage durations were sampled from a Weibull distribution function with shape parameter 2, except for the duration of the early latent stage of
HSV-2 and the interval between recurrent HSV-2 ulcers, which used exponential distribution functions; †per contact; equal for recognized and
unrecognized episodes; ‡both for susceptibility (in HIV negative partner) and infectivity (in HIV positive partner); §except during recurrent ulcers.
F, female; M, male; na, not applicable.
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model predict a realistic prevalence level and a realistic
fraction of ulcers attributable to chancroid (see Results). The
downward adjustment also served as a simplistic represen-
tation of reduced sexual activity during painful ulcers, which
was not explicitly modelled.
Syphilis was represented by two consecutive stages, with
the first, the “infectious” stage, corresponding roughly to pri-
mary and secondary syphilis.65 In the absence of effective
treatment, syphilis patients progress to a non-infectious
“latent” stage. For computations of ulcer incidence, we
assumed that each syphilis infection causes two ulcers during
the infectious stage. Syphilitic ulcers were specified to be less
often symptomatic relative to chancroid.66–68
HIV infection was specified as four subsequent stages,
named primary HIV infection, asymptomatic stage, sympto-
matic pre-AIDS stage, and AIDS. These stages, which were
defined according to relative levels of viral shedding and
symptomatology,69–72 differed in their relative infectivity as well
as in their effect on ulcerations caused by HSV-2 (see below).
HIV transmission probabilities were modelled in a “bath tub”
pattern, with infectivity being highest during primary HIV
disease and during AIDS.70 71 73 Sexual activity and frequency
of intercourse were assumed not to be altered during the
symptomatic stages of HIV infection.
Interactions between STDs and HIV
We assumed that STDs enhance the infectivity with HIV and
the susceptibility to HIV, by a factor varying with the disease
stage (table 1). In the absence of knowledge on STD cofactor
magnitudes from experimental studies, we estimated these
variables from mathematical calculations, based on observa-
tional studies among commercial sex workers and clients in
Nairobi.74 75 In line with recent insights,75 the resulting cofactor
values were lower than those assumed in previous model
studies. In case of multiple cofactors (for example, one partner
in an HIV discordant couple withmultiple concurrent STDs, or
both partners with one or more STDs), the maximum cofactor
for any single STD applied. The relative cofactor magnitudes of
different ulcerative STDs were chosen in line with their
relative clinical severity. For the infectious stage of syphilis,
during which several ulcer episodes may occur
intermittently,65 an average cofactor effect of 10-fold was
applied throughout.
Besides cofactor effects of STDs on HIV transmission, inter-
actions between HIV and STD may include an effect of immu-
nosuppression during advanced HIV disease on the duration
and frequency of herpetic ulcers.13 76 HIV disease is associated
with three- to fourfold increases in the number of culture
positive days77–80 and the incidence of clinical ulcers,81 part of
which may reflect the fact that ulcer episodes last longer.79 In
line with these data,we assumed that during the symptomatic
stages of HIV infection (table 1), the duration and the
frequency of recurrent herpetic ulcers, as well as the remain-
ing duration of the early latent stage (during which ulcers
recur), are doubled. Possible effects of HIV on the natural his-
tory of chancroid and syphilis13 were ignored.
STD intervention
The simulated STD intervention increased the cure rate of
symptomatic episodes of gonorrhoea, chlamydia, syphilis, and
chancroid from 5% to 38%. This figure was based on estimates
of coverage and cure rates in a trial of syndromic STD
treatment in Mwanza, Tanzania.82 As a simplification in the
model, only the symptomatic STD for which the patient
sought treatment was cured; concurrent asymptomatic infec-
tions were not. The simulated intervention was initiated in
1981, 1988, or 1998 (the third, 10th, or 20th year of the HIV
epidemic, respectively), and was sustained throughout the
simulation period.
Simulation design
In order to reduce random fluctuations associated with
stochastic simulations, 100 simulation runs were conducted
for each scenario. All outcomes are reported as averages over
100 runs, in the general adult population aged 15–49 years.
RESULTS
Uganda epidemic and influence of behaviour change
Figure 1 shows the simulated prevalence of STDs and HIV over
time for Uganda and in the hypothetical Uganda-like popula-
tion without behavioural change. The simulated prevalences
Figure 1 Simulated prevalences (%) of sexually transmitted diseases and HIV in adults (15 to 49 years), for rural Uganda and a hypothetical
Uganda-like population without a behaviour change. Syphilis: RPR+/TPHA+ any titre83; HSV-2: seroprevalence. Mean of 100 simulated
populations. Empirical data, for comparison, for 1992–96 from rural Rakai (baseline comparison arm in STD mass treatment trial and pretrial
cohort study; for gonorrhoea and chlamydia 1994–96: subsample aged 15 to 29 years; gonorrhoea data 1979: random subsamples of the
general adult population in 1971–72 in rural Ankola and Teso districts6).
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of gonorrhoea and chlamydia between 1994 and 1996 in the
Uganda simulation are in line with data from Rakai (fig 1,
panels A and B).83 The simulated prevalence of syphilis (fig 1C)
matches that measured in Rakai between 1994 and 1996, and
the simulated stage distribution—with the majority of preva-
lent cases being in late syphilis stages—was in line with the
observed low RPR titres in infected cases in Rakai. In addition,
simulated age specific seroprevalence of HSV-2 (fig 1E) is con-
sistent with empirical data for themale and female population
aged 15 to 29 years from Rakai and for males and females of
all ages from neighbouring rural Masaka (not shown).84
After 1986, STD prevalences fall in the Uganda simulation,
following the assumed behavioural risk reduction in 1986 (fig
1, panels A–E). The simulated decline in syphilis prevalence
matches that observed in Rakai between 1992 and 1996,
although it is somewhat too early. The simulated prevalence
fall is fastest and largest for chancroid. Because chancroid has
the lowest reproductive number, control strategies of moder-
ate intensity—like the assumed behavioural change—can
have most impact on this STD.85 The prevalence decline is
comparatively slow and small for HSV-2 (from 48% to 43% in
1995), for two reasons. As HSV-2 is a lifelong infection with a
high baseline prevalence and recurrent nature, a reduction in
herpetic ulceration can only follow from reductions in new
infections in the youngest age groups. Thus reduced HSV-2
transmission takes a long time to affect HSV-2 seroprevalence
at a population level. Furthermore, the behavioural effect is to
some extent counterbalanced by the assumed enhancement of
herpetic ulceration in HIV patients, which acts to increase
HSV-2 transmission.
HIV prevalence in the Uganda simulation peaks at 17%
around 1990, after which it stabilises and starts a slow decline,
in line with trends in assumed risk behaviour and STD rates
(fig 1F). This level and time trend matches observations
between 1994 and 1996 in Rakai.28 39 44 The simulated stable
HIV prevalence level between 1989 and 1992 matches the sta-
bility observed in earlier prevalence studies in Rakai,
neighbouring rural Masaka33 37 and Kampala.32 40 86
In the hypothetical population without behavioural change,
prevalences of the bacterial STD also decrease during the
1990s, but only moderately (fig 1, panels A–D). These declines
result from excess HIV related mortality in high risk groups,
which lowers the overall level of risk behaviour in the popula-
tion. The decline is most pronounced for chancroid, for which
prevalence falls from 3.1% in 1990 to 2.7% by 2000. The preva-
lence of HSV-2, in contrast, remains stable at 48% throughout
the HIV epidemic in this scenario (fig 1E), owing to the coun-
terbalancing effect of enhanced herpetic ulceration in HIV
patients.
Effect of the HIV epidemic on STD spectrum
In order to assess the implications of HIV induced changes in
STD spectrum for STD management, we examined the
incidence and distribution of cases of ulcerative and non-
ulcerative STD over the different aetiologies. To do this, we
derived distributions of aetiologies of incident syndromes,
based on simulated incidence of herpetic and syphilitic ulcers,
and episodes of chancroid, gonorrhoea, and chlamydia. For
comparison between simulation outcomes and data from STD
clinic populations, we focus on recognised STD syndromes,
using the symptom recognition probabilities shown in table 1.
Before the HIV epidemic, the majority (62%) of incident
recognised genital ulcer disease (GUD) in the simulated
population are caused by chancroid (fig 2A), while 29% and
9%, respectively, are caused by HSV-2 and syphilis.
By year 2000 in the Uganda epidemic, the incidence of
chancroid has fallen markedly as a result of the behaviour
change; consequently the proportion of GUD due to chancroid
has decreased to 13%. The proportion of incident GUD attrib-
uted to syphilis is relatively constant throughout the epidemic
(9–12%). Among ulcers of bacterial origin, syphilis accounts
for only 12% of cases before the HIV epidemic, the remainder
being accounted for by chancroid. Owing to the larger fall in
chancroid relative to syphilis upon behaviour change, by year
2000 almost half of bacterial ulcers are caused by syphilis.
Because of the relatively large falls in syphilis and especially
chancroid, the proportion of GUD attributed to herpes
increases to 75% in 2000. This effect is enhanced by an abso-
lute increase in the incidence of herpetic ulcers, resulting from
the assumed increase in herpetic ulceration in HIV patients.
Of the simulated non-ulcerative STDs, chlamydia and gon-
orrhoea cause about 35% and 65% of episodes of recognised
genital discharge/dysuria, respectively, before the HIV epi-
demic (fig 2B). In the model, these two infections accounted
for all urethritis and cervicitis morbidity, because other genital
tract infections like trichomonas and bacterial vaginosis were
not simulated.Over the course of the HIV epidemic, chlamydia
would become slightly more important relative to gonorrhoea,
accounting for 38% of non-ulcerative STD episodes by 2000 in
the Uganda simulation. This is because chlamydia rates fall
less with behaviour change than gonorrhoea rates (fig 1, pan-
els A and B). Overall, the proportion of ulcerative STD among
all incident recognised STDs increases from 51% to 59%
during the Uganda epidemic.
The simulated shift in STD distribution reflects the time
trends in the prevalence of the respective STD (fig 1, panels C,
D, and E). In the hypothetical population without behaviour
Figure 2 Distribution of recognised incident sexually transmitted
disease (STD) syndromes over the different aetiologies before and
during the HIV epidemic (calendar years 1978 and 2000,
respectively) among adults (15 to 49 years) in the two simulated
populations. (A) ulcerative STD; (B) non-ulcerative STD. Mean of 100
simulated populations.
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change, time trends in STD spectrum are in the same
direction, but much less pronounced.
Impact of STD treatment over time
In the hypothetical population with unchanged behaviour, a
programme of sustained improvement in STD treatment
reduces STD prevalences considerably (fig 3A). The reduction
is largest and fastest for chancroid. This is not only because of
chancroid’s relatively low reproductive number, but also
because a large proportion of chancroid episodes are sympto-
matic (table 1) and hence amenable to syndromic treatment.
The prevalence decline upon the start of improved STD treat-
ment is comparatively slow and limited for syphilis. This
reflects the long duration of the latent stage of syphilis, which
counts as prevalent but does not cause genital symptoms
(table 1) and is therefore not reached with syndromic
approach.
In the Uganda simulation (fig 3B), STD interventions
implemented after 1986 cause STD prevalences to fall less in
absolute terms compared with the population without behav-
iour change, because prevalences have already been reduced
before the STD intervention by behaviour change. As an over-
all result, the equilibrium STD rates during sustained STD
treatment are much lower in the Ugandan population than in
the hypothetical population without behaviour change. An
exception is chancroid, which is also almost eradicated by the
simulated improvement of STD treatment in the population
with unchanged behaviour.
For both populations, the effect of improved treatment on
STD prevalences is relatively similar at different time points of
implementation. However, with later implementation the
prevalence under sustained syndromic treatment is temporar-
ily slightly lower than with earlier implementation, as can be
seen in the crossing of the prevalence curves for all STD (fig 3).
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This is explained from an indirect effect of STD treatment on
HIV spread, through a reduction in STD cofactor burden.With
early implementation of improved STD management, HIV
spread is reduced in the simulation (not shown); therefore the
effect of selective HIV attributable mortality on STD preva-
lences is less marked, leaving higher STD prevalences.
The prevalence of herpes, which is not curable, is unaffected
by improved syndromic treatment (not shown).
DISCUSSION
The simulations showed that severe HIV epidemics can affect
STD epidemiology through multiple effects. Selective HIV
attributable mortality in high risk groups decreases the occur-
rence of risk behaviours, and hence STD levels, on a
population level. A more indirect effect ensues from behav-
ioural risk reduction during the epidemic, as we inferred was
the case for Uganda. Both effects are particularly strong for
chancroid (fig 1). Of all bacterial STDs, chancroid has the low-
est reproductive number, making it relatively sensitive to con-
trol efforts or non-programme related behavioural changes.
HSV-2 was least responsive to both selective mortality and
behavioural risk reduction. This reflects its long duration,
because of which changes in HSV-2 incidence or HIV related
mortality affect HSV-2 seroprevalence relatively little. In addi-
tion, the high reproductive number resulting from the high
baseline HSV-2 seroprevalence ensures that even after reduc-
tions in partner change rates,most uninfected individuals will
sooner or later get exposed to at least one infected partner
anyway.
In the simulations, behavioural change influenced STD epi-
demiology much more than the natural HIV dynamics. The
relative magnitudes of these effects are, however, not known
empirically, as they depend on unknown behavioural charac-
teristics.
The epidemiology of STD and HIV in Uganda was best fitted
by a model assuming considerable reductions in prostitution
and in partner change rates after 1986. It in fact proved
impossible to have STDSIM reproduce the observed decline in
HIV prevalence in the 1990s without assuming some form of
behaviour change in the late 1980s, for any combination of
values for non-behavioural parameters codetermining HIV/
STD transmission dynamics and the rapidity of saturation of
the HIV epidemic (simulations not shown). The best fit was
obtained if the behaviour change was assumed to start in
1986. This change is compatible with the restored stability
after the end of the Ugandan civil war in that year, and the
subsequent adoption of the national AIDS control pro-
gramme, or both. The resulting simulation outcomes provided
reasonable fit against survey data on sexual behaviour and
epidemiology from Rakai and other Uganda regions in the
1990s,30–36 and they corroborate the conclusions from earlier
models of Uganda.32 40 However, the scarcity of survey data on
the period before 1989 precludes certainty about whether the
assumed type and strength of behaviour change was realistic.
For example, it is conceivable that the risk level in the early
1980s was even higher than assumed, and the magnitude of
behaviour change larger, or vice versa. Also, the behavioural
change may in reality have been limited to a subset (or other
types) of risk or protective behaviours as compared with those
simulated. Simulations specifying changes in either prostitu-
tion or partnership change rates alone (and in varying
degrees), however, indicate that the main conclusions would
then be unaltered. Furthermore, it is unclear to what extent
the behavioural trends in Uganda that coincided with the
sociopolitical stabilisation are generalisable to other sub-
Saharan African populations, although increasing numbers of
sub-Saharan African countries have recently documented
reduction in risk behaviour.31–33 39 87–90
The effect of selective HIV mortality depends critically on
supply and demand dynamics of sexual behaviour.91 92 The
STDSIM model assumes that sexual promiscuity, represented
as the frequency at which men have random one-off contacts
with female sex workers, is a lifelong characteristic, which is
not influenced by changes in sexual networks resulting from
AIDS related mortality. For longer term partnerships, in con-
trast, supply and demand dynamics in the model cause
non-promiscuous men and women to increase their partner
change rate once the highest active individuals have died from
AIDS. How realistic this choice is among the two extremes
(totally individually determined or totally network deter-
mined) is unknown. Sensitivity analyses indicated that the
magnitude of STD reduction from selective HIV-attributable
mortality did not depend on the assumed STD/HIV cofactor
effects (not shown).
A third effect of HIV on STD epidemiology is through
immunosuppression during advanced HIV disease.13 76 At a
simulated magnitude of enhancement of herpetic ulceration
by HIV disease effect estimated from clinical studies, the
model predicted an unchanged HSV-2 seroprevalence level
throughout the HIV epidemic for a population without behav-
iour change: the enhanced transmission from HIV patients
just counterbalanced the decline in transmission caused by
selective HIV related mortality. This perhaps unexpectedly
small magnitude of effect in the general population has two
main causes. First,most HSV-2 patients were not infected with
HIV, because of the high prevalence of HSV-2 (48%) relative to
HIV (around 17%). Even in a severe HIV epidemic, not all
HSV-2 patients contract HIV, and those who do die earliest
from HIV related mortality, which limits the combined preva-
lence. Second, the majority of partners of HSV-2/HIV patients
are already infected with HSV-2, so that increased infectivity
does not always actually increase transmission in the popula-
tion. No data are available on HSV-2 seroprevalence over time
periods spanning the course of sub-Saharan African HIV
epidemics20 to support or refute the predicted lack of change in
HSV-2 seroprevalence. Simulations with stronger effects of
HIV would result in absolute increases during the HIV
epidemic in HSV-2 seroprevalence.49 However, this would shift
age peaks in HSV-2 seroprevalence toward the youngest age
groups, which is inconsistent with findings from any recent
sub-Saharan African serosurvey.93 94
As a result of the combined STD/HIV interactions, the HIV
epidemic considerably shifted the spectrum of ulcerative STDs
in the Uganda simulation (fig 2). A marked decrease in
relative importance as a cause of GUD was predicted for chan-
croid. Genital herpes, by contrast, increased; and owing to the
decrease in chancroid, syphilis became relatively more
common as a bacterial cause of ulcers. The resulting simulated
spectrum of ulcerative STDs for Uganda in the 1990s (fig 2A),
with a predominance of HSV-2, is broadly consistent with
empirical observations in rural Uganda83 and other sub-
Saharan African populations suffering advanced HIV
epidemics.68 95 In rural Rakai, over 80% of reported ulcers with
known aetiology were attributable to HSV-2, 7.5% to
chancroid, and around 10% to syphilis.83 In Kampala,
corresponding proportions were 88%, 9%, and 4%.96 The simu-
lated decrease during the HIV epidemic in chancroid and rela-
tive increase in herpes can also explain ecological observations
that African populations with severe HIV epidemics have less
chancroid and more herpes among ulcer cases, and more ulcer
cases compared with non-ulcer cases relative to populations
with more limited HIV spread,20 97–99 and it explains the appar-
ent replacement of chancroid by HSV-2 as the predominant
cause of ulcers in countries with severe HIV
epidemics.18–21 67 97 100–104
In the simulations, chancroid accounted for a larger
proportion of diagnosed GUD (18% in 1995) than observed in
Rakai at this time (7.5%).83 Several factors may explain this
discrepancy. First, we may have underestimated the extent of
behaviour change that occurred in this population. Further-
more, the assumed behaviour change in Rakai may in reality
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have involved not only reductions in partner change rates, but
also increased condom use and improved treatment for
curable STDs. As HSV-2 is incurable and condoms may be
relatively ineffective against herpes transmission from her-
petic ulcers occurring outside the genitals, these modes of risk
reduction can be expected to affect chancroid (and syphilis)
more than they affect HSV-2. Consequently, ignoring them in
the model may have resulted in too small a shift in the aetio-
logical distribution of GUD. Third, the Rakai aetiological
distribution was based on fairly small numbers of samples
tested, and the fractions thereof diagnosed as chancroid may
by chance have been extremely low. Finally, lacking empirical
data on the population prevalence of chancroid in Uganda, we
cannot exclude the possibility that the simulated level of
chancroid spread (fig 1D) was unrealistically high throughout
the simulation.
Shifts in STD spectrum during the HIV epidemic have sev-
eral implications for STD control. Importantly for clinical STD
management, they may cause the sensitivity and specificity of
earlier validated syndromic treatment algorithms to change.
As more andmore ulcers would be caused by herpes instead of
chancroid and syphilis, syndromic treatment of ulcers with
antibiotics—which cures syphilis and chancroid but not
herpes—may become less cost-effective. Shifts among bacte-
rial STDs might also dictate changes in treatment algorithms.
For example, for settings with limited resources not allowing
the prescription of more than one drug at a time, the relative
increase in syphilis relative to chancroid might imply that the
drug of first choice would no longer be ciprofloxacin (targeting
chancroid), but penicillin (targeting syphilis). This illustrates
the importance of monitoring the validity of treatment
algorithms and the aetiology of GUD or genital discharge.
For outreach forms of STD control, it is relevant that the
declines in prevalence cause STD to become more concen-
trated in core groups of individuals at high risk. For example,
in our simulations, behavioural risk reduction increased the
prevalence ratios for commercial sex workers relative to the
general adult population from 10 to 23 for chancroid, and from
5 to 8 for syphilis, after 14 years. The retreat of STD into higher
risk populations implies that strategies with respect to target
groups may need to be reconsidered, and targeting of
interventions to (the remaining) high risk groups is of
undiminished importance.
Conclusions
In summary, comparing the various determinants of STD epi-
demiology, the behavioural change that seems to have
occurred during the Uganda HIV epidemic was more influen-
tial in the simulations than the effects of selective HIV attrib-
utable mortality and HIV related immunosuppression on
(herpetic) ulceration. Behaviour change also reduced STD
rates more than programmes of improved STD management
would probably have done. However, the simulations also
showed that for high risk populations in which no change in
sexual behaviour has yet occurred improved syndromic STD
management can contribute considerably to lowering the bur-
den of bacterial STDs, both in early and late stages of HIV epi-
demics. In all cases, care for STD patients provides a good
entry for targeting HIV prevention activities to those at high
risk.
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